About this document
Peptide-Drug Conjugates A New Hope For Cancer by dparlaksonmez is a document available to read on EtoBox.
Peptide-drug conjugates (PDCs) are emerging as targeted therapies for cancer, combining homing peptides with cytotoxic payloads to enhance tumor specificity while minimizing damage to healthy tissue. Despite the potential of PDCs, challenges such as metabolic instability and rapid clearance hinder their clinical success, with only Lutathera currently FDA-approved. The review discusses the advancements in linker chemistry and targeting mechanisms that could improve PDC efficacy and expand treatment options f
- Author
- dparlaksonmez
- Language
- EN